Naga Munchetty has recently disclosed that she has been sterilised in order to minimise the impact of adenomyosis on her quality of life. We thought it would be a good idea to release a Blog here at www.pharmascholar.co.uk to consider and explain what adenomyosis is and what the process of sterilisation involves from a healthcare perspective.
Naga Munchetty, a BBC presenter, endured a 32-year battle with adenomyosis, a condition where the uterine lining grows into the muscle wall of the womb. This caused her severe pain, heavy bleeding, vomiting and fainting every two weeks since her teenage years. Despite seeking medical help, she was repeatedly dismissed until a private doctor diagnosed her in 2022. Naga opted for sterilisation in 2019, believing it was her only option to alleviate her symptoms. She and her husband had decided against having children and hormonal treatments were unsuitable for her lifestyle. The procedure involved keyhole surgery to block or cut her fallopian tubes. While sterilisation did not cure adenomyosis, it helped manage her symptoms and provided relief from the debilitating pain.
Sterilisation is a permanent contraceptive method involving surgical intervention to prevent pregnancy. In women, it typically involves tubal ligation where the fallopian tubes are blocked or cut preventing sperm from reaching the egg. In men, vasectomy is the equivalent procedure, severing the vas deferens to stop sperm from entering the semen. Sterilisation is highly effective, with a success rate exceeding 99%. It is often chosen by individuals who are certain they do not want children or cannot use other contraceptive methods due to medical reasons.
The procedure is relatively quick, often performed as outpatient surgery under local or general anesthesia. Recovery is usually swift, with most individuals resuming normal activities within a few days. Sterilisation does not affect hormonal balance or sexual function, making it a preferred choice for many.
Beyond contraception, sterilisation can offer significant health benefits for individuals with conditions like adenomyosis or endometriosis. These conditions cause severe pelvic pain, heavy menstrual bleeding and other debilitating symptoms. By preventing pregnancy, sterilisation eliminates the hormonal fluctuations associated with menstrual cycles, which can exacerbate these conditions. For some, it provides a sense of control over their reproductive health and alleviates the physical and emotional toll of chronic gynaecological issues.
Positive health outcomes after sterilisation include reduced risk of pelvic inflammatory disease, which can occur when bacteria travel through the reproductive tract. It also eliminates the risk of ectopic pregnancies, where a fertilised egg implants outside the uterus, a potentially life-threatening condition. For individuals with gynaecological disorders, sterilisation can significantly improve quality of life by reducing pain and discomfort associated with their condition.
However, sterilisation is irreversible and individuals must carefully consider their decision. While it offers freedom from contraception and its associated side effects, it is not suitable for those who may wish to conceive in the future. Counselling and thorough medical evaluation are essential to ensure that sterilisation aligns with an individual's long-term health and lifestyle goals.
We hope you have found this Blog entry both interesting and informative. To book your medical education / career development appointment with us then please click here.
Naga Munchetty: ‘Sterilisation was my only option’.